Liver regeneration and tumor stimulation - A review of cytokine and angiogenic factors

被引:58
作者
Christophi, Christopher [1 ]
Harun, Nadia [1 ]
Fifis, Theodora [1 ]
机构
[1] Univ Melbourne, Dept Surg, Melbourne, Vic 3084, Australia
关键词
colorectal carcinoma; liver resection; liver regeneration; cytokines; angiogenesis; growth factors; tumor recurrence;
D O I
10.1007/s11605-007-0459-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Liver resection for metastatic (colorectal carcinoma) tumors is often followed by a significant incidence of tumor recurrence. Cellular and molecular changes resulting from hepatectomy and the subsequent liver regeneration process may influence the kinetics of tumor growth and contribute to recurrence. Clinical and experimental evidence suggests that factors involved in liver regeneration may also stimulate the growth of occult tumors and the reactivation of dormant micrometastases. An understanding of the underlying changes may enable alternative strategies to minimize tumor recurrence and improve patient survival after hepatectomy.
引用
收藏
页码:966 / 980
页数:15
相关论文
共 194 条
[1]
Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors [J].
Adam, R ;
Laurent, A ;
Azoulay, D ;
Castaing, D ;
Bismuth, H .
ANNALS OF SURGERY, 2000, 232 (06) :777-784
[2]
Vascular endothelial growth factor induces heparin-binding epidermal growth factor-like growth factor in vascular endothelial cells [J].
Arkonac, BM ;
Foster, LC ;
Sibinga, NES ;
Patterson, C ;
Lai, KH ;
Tsai, JC ;
Lee, ME ;
Perrella, MA ;
Haber, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (08) :4400-4405
[3]
Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas [J].
Baker, CH ;
Kedar, D ;
McCarty, MF ;
Tsan, R ;
Weber, KL ;
Bucana, CD ;
Fidler, IJ .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (03) :929-938
[4]
Barbera-Guillem E, 2002, CANCER RES, V62, P7042
[5]
Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor [J].
Bauer, TW ;
Fan, F ;
Liu, WB ;
Johnson, M ;
Parikh, NU ;
Parry, GC ;
Callahan, J ;
Mazar, AP ;
Gallick, GE ;
Ellis, LM .
ANNALS OF SURGERY, 2005, 241 (05) :748-758
[6]
Å6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer:: A phase I trial [J].
Berkenblit, A ;
Matulonis, UA ;
Kroener, JF ;
Dezube, BJ ;
Lam, GN ;
Cuasay, LC ;
Brünner, N ;
Jones, TR ;
Silverman, MH ;
Gold, MA .
GYNECOLOGIC ONCOLOGY, 2005, 99 (01) :50-57
[7]
Bermont L, 2000, INT J CANCER, V85, P117, DOI 10.1002/(SICI)1097-0215(20000101)85:1<117::AID-IJC21>3.0.CO
[8]
2-X
[9]
Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression [J].
Biswas, Swati ;
Guix, Marta ;
Rinehart, Cammie ;
Dugger, Teresa C. ;
Chytil, Anna ;
Moses, Harold L. ;
Freeman, Michael L. ;
Arteaga, Carlos L. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (05) :1305-1313
[10]
Mechanisms of disease:: Role of transforming growth factor β in human disease. [J].
Blobe, GC ;
Schiemann, WP ;
Lodish, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) :1350-1358